Outcome 90 days after stroke symptom onset comparing the intervention and control groups, excluding IMS-III
| Outcome | Endovascular group (n (%)) | Control group (n (%)) | OR (95% CI) | p Value |
|---|---|---|---|---|
| mRS 0–2 (functional outcome) | 295 (47) | 170 (26) | 2.48 (1.95 to 3.15) | <0.00001 |
| mRS 0–1 (excellent outcome) | 172 (27) | 83 (13) | 2.59 (1.92 to 3.48) | <0.00001 |
| mRS 0–3 | 400 (63) | 275 (42) | 2.34 (1.87 to 2.94) | <0.00001 |
| Mortality | 97 (15) | 122 (19) | 0.80 (0.60 to 1.08) | 0.14 |
| Symptomatic intracerebral hemorrhage | 26 (4) | 28 (4) | 1.00 (0.58 to 1.71) | 0.99 |
| mRS 5–6 | 139 (22) | 217 (33) | 0.57 (0.44 to 0.73) | <0.00001 |
IMS-III, Interventional Management of Stroke-III; mRS, modified Rankin Scale score.